한글목차

체액 채취 및 진단 시장 규모는 2025년 400억 7,000만 달러에서 2026-2034년 CAGR 6.94%로 성장하여 2034년에는 733억 달러에 달할 것으로 예측됩니다.

세계 체액 채취 및 진단 시장은 정확하고 빠른 질병 진단에 대한 수요 증가로 인해 강력한 성장세를 보이고 있습니다. 혈액, 소변, 뇌척수액, 타액 등의 체액은 다양한 병태생리를 감지하는 데 매우 중요한 역할을 합니다. 예방의료와 정기 건강검진에 대한 인식이 높아지면서 진단검사의 이용이 확대되고 있습니다. 전 세계 진단검사기관 및 병원의 확대도 시장 발전에 기여하고 있습니다.

주요 촉진요인으로는 당뇨병, 암, 심혈관 질환 등 만성질환의 유병률 증가를 들 수 있습니다. 진단 장비와 저침습적 채취 방법의 기술적 발전으로 환자의 편의성과 검사 정확도가 향상되고 있습니다. 포인트 오브 케어 검사 솔루션의 도입 확대가 시장 성장을 더욱 가속화하고 있습니다. 또한, 신흥국의 의료 인프라 강화를 위한 정부의 이니셔티브이 진단 서비스 접근성 확대에 기여하고 있습니다.

분자진단 및 자동화 검사 시스템의 지속적인 혁신으로 이 시장 전망은 여전히 유망합니다. 디지털 헬스 기술과 데이터 분석의 통합으로 진단 정확도가 향상될 것으로 기대됩니다. 각 업체들은 보다 신속하고 비용 효율적인 검사 키트 개발에 투자하고 있습니다. 의료시스템이 조기발견과 맞춤형 의료를 중시하는 가운데 체액진단에 대한 수요는 앞으로도 꾸준히 확대될 것입니다.

목차

제1장 서론

제2장 주요 요약

제3장 시장 변수, 동향, 프레임워크

제4장 세계의 체액 채취 및 진단 시장 : 샘플별

제5장 세계의 체액 채취 및 진단 시장 : 제품별

제6장 세계의 체액 채취 및 진단 시장 : 기술별

제7장 세계의 체액 채취 및 진단 시장 : 용도별

제8장 세계의 체액 채취 및 진단 시장 : 지역별

제9장 경쟁 구도

제10장 기업 개요

영문목차

The Body Fluid Collection And Diagnostics Market size is expected to reach USD 73.30 Billion in 2034 from USD 40.07 Billion (2025) growing at a CAGR of 6.94% during 2026-2034.

The Global Body Fluid Collection and Diagnostics Market is witnessing strong growth due to the increasing demand for accurate and early disease diagnosis. Body fluids such as blood, urine, cerebrospinal fluid, and saliva play a crucial role in detecting various medical conditions. Growing awareness about preventive healthcare and routine health check-ups is boosting the use of diagnostic tests. The expansion of diagnostic laboratories and hospitals worldwide is also contributing to market development.

Key drivers include the rising prevalence of chronic diseases such as diabetes, cancer, and cardiovascular disorders. Technological advancements in diagnostic equipment and minimally invasive collection methods are improving patient comfort and test accuracy. The increasing adoption of point-of-care testing solutions is further accelerating market growth. Additionally, government initiatives to strengthen healthcare infrastructure in emerging countries are expanding access to diagnostic services.

Future prospects for this market remain promising, with continuous innovation in molecular diagnostics and automated laboratory systems. The integration of digital health technologies and data analytics is expected to improve diagnostic precision. Companies are investing in the development of faster and more cost-effective testing kits. As healthcare systems emphasize early detection and personalized medicine, the demand for body fluid diagnostics will continue to grow steadily.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Sample

• Blood
• Saliva
• Urine
• Cerebrospinal Fluid

By Product

• Tests/Services
• Kits & Consumables
• Instruments

By Technology

• Next Generation Sequencing
• Polymerase Chain Reaction (PCR)
• Fluorescence in situ hybridization (FISH)
• Others

By Application

• Diagnostics & Monitoring
• Therapeutic Decision Making
• Prognostics & Screening

COMPANIES PROFILED

• Thermo Fisher Scientific Inc, BioRad Laboratories, Illumina Inc, Guardant Health, Qiagen, Johnson Johnson, Laboratory Corporation of America Holdings, Biocept Inc, F HoffmannLa Roche Ltd, MDxHealth SA
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BODY FLUID COLLECTION AND DIAGNOSTICS MARKET: BY SAMPLE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Sample
• 4.2. Blood Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Saliva Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Urine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Cerebrospinal Fluid Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BODY FLUID COLLECTION AND DIAGNOSTICS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Product
• 5.2. Tests/Services Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Kits & Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BODY FLUID COLLECTION AND DIAGNOSTICS MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Technology
• 6.2. Next Generation Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Polymerase Chain Reaction (PCR) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Fluorescence in situ hybridization (FISH) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BODY FLUID COLLECTION AND DIAGNOSTICS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Application
• 7.2. Diagnostics & Monitoring Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Therapeutic Decision Making Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Prognostics & Screening Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL BODY FLUID COLLECTION AND DIAGNOSTICS MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Sample
  • 8.2.2 By Product
  • 8.2.3 By Technology
  • 8.2.4 By Application
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Sample
  • 8.3.2 By Product
  • 8.3.3 By Technology
  • 8.3.4 By Application
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Sample
  • 8.4.2 By Product
  • 8.4.3 By Technology
  • 8.4.4 By Application
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Sample
  • 8.5.2 By Product
  • 8.5.3 By Technology
  • 8.5.4 By Application
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Sample
  • 8.6.2 By Product
  • 8.6.3 By Technology
  • 8.6.4 By Application
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL BODY FLUID COLLECTION AND DIAGNOSTICS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Thermo Fisher Scientific Inc
  • 10.2.2 Bio-Rad Laboratories
  • 10.2.3 Illumina Inc
  • 10.2.4 Guardant Health
  • 10.2.5 Qiagen
  • 10.2.6 Johnson & Johnson
  • 10.2.7 Laboratory Corporation Of America Holdings
  • 10.2.8 Biocept Inc
  • 10.2.9 F. Hoffmann-La Roche Ltd
  • 10.2.10 MDxHealth SA